<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02284334</url>
  </required_header>
  <id_info>
    <org_study_id>14-011156</org_study_id>
    <nct_id>NCT02284334</nct_id>
  </id_info>
  <brief_title>Glycemic Index in Mitochondrial Disease</brief_title>
  <official_title>Acute Effects of Dietary Glycemic Index on Lactate and Glucose Homeostasis in Individuals With Primary Mitochondrial Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Philadelphia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are conducting a research study on nutrition in mitochondrial disease. The&#xD;
      investigators are interested in the kind of carbohydrates that people eat. Carbohydrates are&#xD;
      an important source of energy. Certain kinds of carbohydrates tend to raise blood sugar more&#xD;
      in healthy people, and others tend to raise blood sugar less in healthy people. The&#xD;
      investigators would like to know if by eating the &quot;right&quot; type of carbohydrate, people with&#xD;
      mitochondrial disease can avoid high lactate levels, high blood sugar levels, and, later, low&#xD;
      blood sugars.&#xD;
&#xD;
      In this study, this question will be answered by finding out how people with mitochondrial&#xD;
      disease respond to two different test meals containing different kinds of carbohydrates.&#xD;
      Neither participants nor the investigators will know which kind of test meal participants are&#xD;
      eating.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This research study involves two study visits at CHOP, each around 6 to 8 hours long. The&#xD;
      time the visit takes can depend on how long it takes to complete the study procedures listed.&#xD;
      This can be different from person to person. The length of time between Visit #1 and Visit #2&#xD;
      will be between 2 weeks and 3 months. Overall study participation will not exceed 6 months.&#xD;
&#xD;
      The study involves the following tests and procedures. These happen at each of the two&#xD;
      visits:&#xD;
&#xD;
        -  Interviews: A team member will take the participant's medical history, along with a&#xD;
           listing of any medications s/he is taking. Throughout the study the participant will be&#xD;
           asked to report if s/he thinks that anything bad has happened as a result of the study.&#xD;
&#xD;
        -  3-day diet record: The investigator will collect the record the participant made of&#xD;
           everything s/he ate for the 3 days before the study visit.&#xD;
&#xD;
        -  Physical Examination: The investigators will measure the participant's weight, height,&#xD;
           blood pressure, heart rate and respiratory rate, and waist circumference. If the&#xD;
           participant is under age 21 years, a pediatric endocrinologist will check how far s/he&#xD;
           is along in puberty. For both boys and girls, pubic hair growth will be checked. For&#xD;
           girls, breast development will be checked. For boys, testicular development will be&#xD;
           checked. This examination will take approximately 2 minutes and will be done in a&#xD;
           private room.&#xD;
&#xD;
        -  Pregnancy Test (female subjects): If a female participant is eleven years old or older&#xD;
           and/or has already started having periods, she will be asked to take a pregnancy test&#xD;
           before starting this study.&#xD;
&#xD;
        -  Questionnaires: Investigators will ask the participant to fill out questionnaires on&#xD;
           his/her physical function and well-being. These are designed for people with&#xD;
           mitochondrial disease (or for parents of children with mitochondrial disease). They&#xD;
           should take around 20 minutes.&#xD;
&#xD;
        -  Pre-Test Fast: The participant will not be able to eat or drink anything except plain,&#xD;
           unflavored water (i.e., you will &quot;fast&quot;) for at least 4 hours before the mixed-meal&#xD;
           tolerance test starts. S/he will get the test meal at that time. S/he will receive a&#xD;
           recommendation when the visit is scheduled when to begin fasting. This recommendation is&#xD;
           designed for no more than 10 hours of fasting, or the participant's longest usual&#xD;
           overnight fast, whichever is shorter.&#xD;
&#xD;
        -  Mixed Meal Tolerance Test (MMTT): The test includes placement of an intravenous (IV)&#xD;
           line in the participant's arm/hand to make taking the blood samples easier. With the IV&#xD;
           in place, the participant will not need to be stuck again for any further blood draws,&#xD;
           unless the IV stops working. If s/he prefers, a numbing cream can be placed on your skin&#xD;
           for about 45 minutes before this test to numb the area. Once the IV is in place, the&#xD;
           participant will receive a test &quot;shake&quot;. S/he will have about 30 minutes to finish the&#xD;
           shake. Over the next 4 hours, blood will be drawn every 30 minutes from the IV line. The&#xD;
           total amount of blood drawn for the MMTT will be a little less than 2 tablespoons.&#xD;
&#xD;
        -  Cognitive Testing: Two times during the MMTT participants will be asked to perform some&#xD;
           testing on a computer (for example, pressing a button as soon as you see a symbol&#xD;
           appear). Each test will take around 14 minutes and tests things like attention and&#xD;
           reaction time. We will show you how these tests work before the MMTT.&#xD;
&#xD;
        -  Dual Energy X-ray Absorptiometry (DXA) Scan: A special x-ray of the body called a DXA&#xD;
           scan will be done to measure the amount of fat and lean (non-fat) tissue in the&#xD;
           participant's body. During the DXA scan, the participant will be asked to lie flat on&#xD;
           your back on a table as the scanning machine moves above the participant's body. The DXA&#xD;
           scan is like an X-ray, and takes about 5-10 minutes. This test is painless and does not&#xD;
           involve any needles.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>lactate area under the curve (AUC) for 3 hours after MMTT</measure>
    <time_frame>visit 1 (baseline, 0 months), visit 2 (around 1 month)</time_frame>
    <description>within-subject change in lactate area under the curve (AUC) for 3 hours (low- vs. high- glycemic index)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hypoglycemia (&lt; 70 mg/dL) post-MMTT</measure>
    <time_frame>visit 1 (baseline, 0 months), visit 2 (around 1 month)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glucose area under the curve (AUC) for 3 hours after MMTT</measure>
    <time_frame>visit 1 (baseline, 0 months), visit 2 (around 1 month)</time_frame>
    <description>within-subject change in glucose area under the curve (AUC) for 3 hours (low- vs. high- glycemic index)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insulin area under the curve (AUC) for 3 hours after MMTT</measure>
    <time_frame>visit 1 (baseline, 0 months), visit 2 (around 1 month)</time_frame>
    <description>within-subject change in insulin area under the curve (AUC) for 3 hours (low- vs. high- glycemic index)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>combined index of attention (CPT-III) during MMTT</measure>
    <time_frame>visit 1 (baseline, 0 months), visit 2 (around 1 month)</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">18</enrollment>
  <condition>Mitochondrial Diseases</condition>
  <arm_group>
    <arm_group_label>Low GI-High GI</arm_group_label>
    <description>Two study visits are separate by around one month.&#xD;
For this arm, test meal (Visit 1): low-glycemic index; test meal (Visit 2): high-glycemic index</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High GI-Low GI</arm_group_label>
    <description>Two study visits are separate by around one month.&#xD;
For this arm, test meal (Visit 1): high-glycemic index; test meal (Visit 2): low-glycemic index</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>test meal</intervention_name>
    <description>low- or high-glycemic index test meal, administered during mixed meal tolerance test</description>
    <arm_group_label>High GI-Low GI</arm_group_label>
    <arm_group_label>Low GI-High GI</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples obtained during MMTT.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with mitochondrial diseases, from existing observational cohort study and/or CHOP&#xD;
        Genetics/Metabolism clinic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Weight &gt; 15 kg&#xD;
&#xD;
          -  Girls â‰¥ 11 years of age and/or who have achieved menarche must have a negative urine&#xD;
             pregnancy test.&#xD;
&#xD;
          -  Genetic and/or biochemical diagnosis of mitochondrial disease.&#xD;
&#xD;
          -  Eat meals by mouth during the day.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetes requiring insulin.&#xD;
&#xD;
          -  Receive daytime total parenteral nutrition (TPN) and/or continuous enteral feedings.&#xD;
&#xD;
          -  Prescribed dietary contraindication to mixed meal tolerance testing, e.g., ketogenic&#xD;
             diet.&#xD;
&#xD;
          -  Any investigational drug use within 30 days prior to enrollment.&#xD;
&#xD;
          -  Pregnant or lactating females.&#xD;
&#xD;
          -  Persons unable to fast for at least 4 hours.&#xD;
&#xD;
          -  Persons who may be allergic to the test meals (shakes).&#xD;
&#xD;
          -  Parents/guardians or subjects who, in the opinion of the Investigator, may be&#xD;
             non-adherent to study schedules or procedures.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 21, 2014</study_first_submitted>
  <study_first_submitted_qc>November 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2014</study_first_posted>
  <last_update_submitted>November 18, 2020</last_update_submitted>
  <last_update_submitted_qc>November 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mitochondrial diseases</keyword>
  <keyword>nutrition</keyword>
  <keyword>glycemic index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitochondrial Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

